Merck/Intervet/Schering-Plough Animal Health is a global, research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services. We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck.
Merck's animal health division, formerly known as Intervet/Schering-Plough Animal Health, announced that it has adopted the name of its parent company and will now be called Merck Animal Health.
It is the world leader in pharmaceuticals and vaccines for aquaculture and major products in its portfolio are the antibiotic AQUAFLOR (florfenicol), the parasiticide SLICE (emamectin benzoate) and the vaccine ranges AQUAVAC and NORVAX. The company is based in Boxmeer, The Netherlands.
We are a highly proactive, robust and diversified company with a strong, scientifically-proven, product portfolio and an ever-growing global reach.
With offices in more than 50 countries, we successfully market our products in over 140 countries and operate a network of manufacturing sites and research and development (R&D) facilities around the world.
With offices in more than 50 countries, we successfully market our products in over 140 countries and operate a network of manufacturing sites and research and development (R&D) facilities around the world.
Russian Fishermen Record a Catch of 4.8 Million Tons in 2024 Russia Fed.
Russian fishermen achieved a total catch of 4.8 million tons of aquatic bioresources, according to the Federal Agency for Fisheries' Industry Monitoring System (ISMS). This milestone highlights si...
Bribery and High Costs Cloud Argentina’s Hake Quota Allocations Argentina
Almost at the same time that the Federal Fisheries Council unanimously approved the CITC's 15-year allocation of hubbsi hake on December 5, the Federal Prosecutor's Office No. 2 of the Mar del Plata J...